Aptorum Group (APM)

• Market cap: $11.6M
• 1 day: -9.09%
• 5 days: -5.8%
• 1 month: -18.75%
• 3 months: -69.41%
• 6 months: 44.2%
• Year to date: -40.91%
• 1 year: 76.63%
• 5 years: -94.47%
• 10 years: -99.09%
• Sector: Healthcare
• Industry: Biotechnology

About: Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Employees: 1